Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted the survey from Feb. 24-26, 2026, among 1,189 U.S. adults, ages 45 and ...
Officials with the FDA have released a draft guidance that aims to help drug developers validate new approach methodologies (NAMs) that can be used in place of animal testing. Based on human-centric ...
Patients on GLP-1 or GLP-1/GIP agonists had significant residual gastric volume if the medication was not held prior to upper endoscopy, unless they were on a clear liquid diet the previous day, ...
Two local health care organizations have joined forces to provide a new center for digestive-health services. Carle Health and Christie Clinic plan to open the Champaign Endoscopy ...
Helio Genomics and Quest Diagnostics have partnered to expand access to a blood-based liver cancer test across the U.S. Starting in April, providers with a Quest account will be able to order ...
The global preimplantation genetic testing market is growing steadily, valued at around US$ 598.4 million in 2026 and projected to reach US$ 1,081.9 million ...
The global preimplantation genetic testing market is growing steadily, valued at around US$ 598.4 million in 2026 and ...
Two local healthcare organizations have joined forces to provide a new center for digestive health services. Carle Health and ...
When David Thau, a lobbyist in Washington, D.C., was 34, he periodically experienced pain in his stomach, irregular bowel movements, blood in his stool and vomiting, and he visited doctors ...
Earnings over $24,480 (2026) before full retirement age reduces Social Security benefits. Claimed Social Security early; half of earnings above the threshold are withheld. Benefits recalculated at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results